Tuesday, July 12, 2005 12:18:35 AM
Not only was it clear enough in the body
of the press release, but it's often not
a good thing to open up a manufacturing
facility to build your own products --
unless you enjoy delays and stock
dilution. I hear that Now Auto doesn't
manufacture the cars they sell either.
I think they took the best approach.
That is starting by distributing products
made by others. That way they start
building up clients and sales quickly
without have to go into debt or dilute
the heck out of the stock to hire
engineers and open a manufacturing facility.
Of course, with hiring engineering and
manufacturing your own product often
comes with long delays. I'm sure most
who have invested in small companies
have at one time or another invested
in a small company that had endless
delays or dilution or debt that came
along with designing or manufacturing
products.
Then, instead of hiring a huge sales
force, they appear to be focusing on
using distributors with knowledge or
connections in certain markets. I
think this is a more effective way
to build market share and get your
name out quickly without the overhead
of a salesforce.
Now, they are creating strategic
partnerships that will give them much
more flexibility as to the GPS products
and software they sell.
Of course, their car businesses are
doing well and hopefully that will
continue so we have two possible ways
to create a $100 million company as
Miller has stated is his goal.
I am very happy with their business plan
so far. Can't be 100% sure it will work
out perfectly, but that's the nature
of all stocks.
BTW, I am very surprised we haven't had
a significant pull-back yet. Maybe that's
yet to come later this week.
T
of the press release, but it's often not
a good thing to open up a manufacturing
facility to build your own products --
unless you enjoy delays and stock
dilution. I hear that Now Auto doesn't
manufacture the cars they sell either.
I think they took the best approach.
That is starting by distributing products
made by others. That way they start
building up clients and sales quickly
without have to go into debt or dilute
the heck out of the stock to hire
engineers and open a manufacturing facility.
Of course, with hiring engineering and
manufacturing your own product often
comes with long delays. I'm sure most
who have invested in small companies
have at one time or another invested
in a small company that had endless
delays or dilution or debt that came
along with designing or manufacturing
products.
Then, instead of hiring a huge sales
force, they appear to be focusing on
using distributors with knowledge or
connections in certain markets. I
think this is a more effective way
to build market share and get your
name out quickly without the overhead
of a salesforce.
Now, they are creating strategic
partnerships that will give them much
more flexibility as to the GPS products
and software they sell.
Of course, their car businesses are
doing well and hopefully that will
continue so we have two possible ways
to create a $100 million company as
Miller has stated is his goal.
I am very happy with their business plan
so far. Can't be 100% sure it will work
out perfectly, but that's the nature
of all stocks.
BTW, I am very surprised we haven't had
a significant pull-back yet. Maybe that's
yet to come later this week.
T
Recent FITY News
- Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health • ACCESS Newswire • 04/15/2026 12:30:00 PM
- Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market • ACCESS Newswire • 04/14/2026 12:30:00 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • GlobeNewswire Inc. • 01/05/2026 06:08:59 PM
- Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • InvestorsHub NewsWire • 01/05/2026 06:00:00 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • GlobeNewswire Inc. • 10/09/2025 02:23:35 PM
- Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer • InvestorsHub NewsWire • 10/09/2025 02:00:00 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • GlobeNewswire Inc. • 09/30/2025 01:56:45 PM
- Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. • InvestorsHub NewsWire • 09/30/2025 01:45:00 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • GlobeNewswire Inc. • 09/23/2025 01:07:25 PM
- Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB • InvestorsHub NewsWire • 09/23/2025 12:35:36 PM
- Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 • InvestorsHub NewsWire • 08/26/2025 01:00:00 PM
- Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing • InvestorsHub NewsWire • 08/22/2025 02:30:00 PM
- Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership • InvestorsHub NewsWire • 07/29/2025 01:00:00 PM
- Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières • InvestorsHub NewsWire • 07/28/2025 12:30:00 PM
- Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • InvestorsHub NewsWire • 07/17/2025 12:30:00 PM
- Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • InvestorsHub NewsWire • 07/10/2025 12:30:49 PM
- Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • InvestorsHub NewsWire • 07/08/2025 12:30:00 PM
- Fifty 1 Labs, Inc. Accelerates Growth with New CEO, BioSentry Division Launch and Shareholder Dividend; Company Pursues Strategic Growth Through UAV Partnership and Targeted Acquisitions in Advanced Tech and Wellness • InvestorsHub NewsWire • 04/30/2025 12:32:59 PM
